Author Question: The recapture of net working capital at the end of a project will A) decrease terminal year free ... (Read 67 times)

Mollykgkg

  • Hero Member
  • *****
  • Posts: 529
The recapture of net working capital at the end of a project will
 
  A) decrease terminal year free cash flow by the change in net working capital times the corporate
  tax rate.
  B) increase terminal year free cash flow.
  C) have no effect on the terminal year free cash flow because the net working capital change has
  already been included in a prior year.
  D) increase terminal year free cash flow by the change in net working capital times the corporate
  tax rate.

Question 2

Transaction balances are used to meet the regular cash needs of the firm, not irregular outflows that
  will be handled with speculative balances.
 
  Indicate whether the statement is true or false



Amiracle

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

B

Answer to Question 2

FALSE



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library